Trade OKUR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
OnKure Therapeutics, Inc. Class A (OKUR) is trading at US$3.40, down 5.03% today as of Sep 8, 16:00 EDT. The company has a market capitalisation of US$159.56M. Over the past 52 weeks, OKUR has traded between US$2.23 and US$5.38. On Syfe you can trade OKUR with $0 commission and add it to your watchlist.
| Previous close | US$3.58 |
|---|---|
| Market cap | US$159.56M |
| 52-week range | US$2.23 – US$5.38 |
| Volume | 114.79K |
| Exchange | US |
Add to Watchlist
Set Price Alert
OnKure Therapeutics, Inc. Class A
OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.
Year: 2024
OnKure Therapeutics, Inc. Class A (OKUR) stock is trading at US$3.40, -5.03% from the previous close of US$3.58.
The market cap for OnKure Therapeutics, Inc. Class A (OKUR) stock is approximately US$159.56M.
The 52-week high for OnKure Therapeutics, Inc. Class A (OKUR) stock is US$5.38.
The 52-week low for OnKure Therapeutics, Inc. Class A (OKUR) stock is US$2.23.
OnKure Therapeutics, Inc. Class A (OKUR) does not currently pay a dividend.
Stay on top of OKUR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
